Effect of Serplulimab in Combination with Neoadjuvant Chemoradiotherap

Introduction

Globally, colorectal cancer (CRC) is the second most common cause of cancer-related death and the third most common cancer.1–3 This disease burden is most noticeable in China,4–6 where 517,000 newly diagnosed cases of CRC…

Continue Reading